Early Access — free while we kick the tires
EdgarHawk

AVLN Avalyn Pharma Inc. Insider Trading

Latest: Insider Bought $10.0M of Shares · May 2026
1 filing analyzed · Latest 2026-05-05
Insider buys
1
Insider sells
0
Unique insiders
1
Direction
Net buying
May 2026
2026-05-05 Cluster
high
Novo Holdings A/S Buy
555,555 shares
$9,999,990
@ $18.00
Significance 7/10

Novo Holdings, a 10% owner, acquires 3.9M shares via conversion and open-market purchase; part of multi-insider buying cluster in newly listed stock.

Novo Holdings, an institutional holder with significant ownership, made a substantial acquisition combining a share conversion and open-market purchase totaling nearly four million shares. This transaction is noteworthy in part because it occurred alongside purchases by two other insiders within a two-week window—a pattern that stands out given the stock's very recent listing status. The stock is currently trading at its 52-week high following its IPO launch, which makes this accumulation at peak pricing somewhat unusual: institutional investors and insiders typically build positions during pullbacks rather than at the upper end of trading range. Novo's track record shows prior open-market purchases, making this part of an existing pattern of accumulation at this company rather than a first-time entry. The company fundamentals and operational trajectory warrant review alongside this large institutional commitment to assess whether the timing reflects conviction in long-term positioning or simply routine portfolio mechanics following the listing event.

More Chemicals and Allied Products companies

Get alerts for AVLN

Add AVLN to your watchlist and we'll email you when an insider files a Form 4 — with our AI's significance score and a plain-English read of what it means.

Sign up — free during early access